FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms
Clinical trial NCT06858618 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06858618
- Sponsor
- Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-08-16
- Primary completion
- 2026-12-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.